Showing results (341-350 of 635) with videos related to
Sort By:
Pageof 64
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.Genes, Chromosomes & Cancer|February 28, 2023
Real-world data for precision cancer medicine-A European perspectivePetros Christopoulos, Richard Schlenk, Daniel Kazdal, et al.Epigenetics|September 6, 2016
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaBenjamin Goeppert, Christina Ernst, Constance Baer, et al.Translational Lung Cancer Research|June 24, 2021
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsiesPetros Christopoulos, Steffen Dietz, Arlou K Angeles, et al.British Journal of Cancer|June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinomaJan Budczies, Eva Romanovsky, Martina Kirchner, et al.Clinical Lung Cancer|July 16, 2026
Chemoimmunotherapy Versus Chemotherapy for Extensive-Stage Small Cell Lung Cancer in the Real-World Setting: Retrospective Study of 904 PatientsKyriaki Dimitriou, Shuo Shi, Antonia Marginenau, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated GenesClemens Kratochwil, Frederik L Giesel, Claus-Peter Heussel, et al.Pathology|December 23, 2017
Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomasMartina Bosic, Martina Kirchner, Dimitrije Brasanac, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinomaBenjamin Goeppert, Lena Frauenschuh, Marcus Renner, et al.Journal of Experimental & Clinical Cancer Research : CR|March 7, 2025
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancerFlorian Janke, Mateo Gasser, Arlou K Angeles, et al.Pageof 64